Decreased green autofluorescence in cancerous tissues is a potential biomarker for diagnosis of renal cell carcinomas.

癌组织中绿色自发荧光的降低是肾细胞癌诊断的潜在生物标志物

阅读:14
作者:Wan Wei, Zou Junrong, Xie Tianpeng, Zeng Liang, Liu Huiquan, Jiang Bo, Liao Yunfeng, Wu Yuting, Wu Gengqing, Zhang Guoxi, Ying Weihai, Zou Xiaofeng
This study primarily focuses on the potential sources of autofluorescence, including keratins (KRT) encoded by KRT1, KRT7, and KRT8, to investigate their contributions to the differences in autofluorescence between cancerous tissues and adjacent non-tumor tissues, as well as their potential for real-time diagnosis of RCC. First, the autofluorescence of renal cell carcinoma (RCC) tissues under 488 nm laser excitation was observed and compared with the autofluorescence of neighboring non-tumor tissues. Then, the effect on the autofluorescence intensity was analyzed by knocking down the KRT1/KRT7 gene. In addition, autofluorescence data were collected from 174 pairs of tumor and adjacent non-tumor tissue samples (from 60 RCC patients). Diagnostic performance was evaluated using ROC analysis to determine the threshold value for tumor autofluorescence intensity. Under 488 nm laser excitation, the intensity of green autofluorescence in cancerous tissues of RCC patients was significantly lower than that in non-tumor tissues. Further analysis showed that KRT1 knockdown resulted in a 73% reduction in autofluorescence intensity, suggesting that KRT1 plays a key role in the reduced autofluorescence observed in tumor tissues. In addition, analysis of autofluorescence data from 174 tumor and adjacent non-tumor tissue samples showed an AUC of 0.880 for ROC analysis, a diagnostic sensitivity and specificity of 0.843 and 0.835, respectively, and a threshold value of 27.45 for using tumor autofluorescence intensity. KRT1 is a major contributor to the tumor autofluorescence observed in RCC. An autofluorescence-based diagnostic model facilitates real-time assessment of surgical margins during partial nephrectomy, thereby potentially improving surgical success rates.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。